| CD14 |
CD14: Monocyte differentiation antigen CD14 precursor |
CANX |
CANX: Calnexin precursor |
2.83 |
Evidence |
|
| CD3E |
CD3E, T3E: T-cell surface glycoprotein CD3 epsilon chain precursor |
LMAN2 |
LMAN2, C5orf8: Vesicular integral-membrane protein VIP36 precursor |
2.83 |
Evidence |
|
| KRT18 |
KRT18: Uncharacterized protein KRT18 |
FADD |
FADD, MORT1: Protein FADD |
2.83 |
Evidence |
|
| KRT18 |
KRT18: Uncharacterized protein KRT18 |
INSR |
INSR: Insulin receptor precursor |
2.83 |
Evidence |
|
| CDC7 |
CDC7, CDC7L1: Cell division cycle 7-related protein kinase |
BCL2 |
BCL2: Apoptosis regulator Bcl-2 |
2.83 |
Evidence |
|
| K-ALPHA-1 |
TUBA1B: Tubulin alpha-1B chain |
GRAP |
GRAP: GRB2-related adapter protein |
2.83 |
Evidence |
|
| RASA4 |
RASA4, CAPRI, GAPL, KIAA0538: Ras GTPase-activating protein 4 |
INSR |
INSR: Insulin receptor precursor |
2.83 |
Evidence |
|
| GNAI3 |
GNAI3: Guanine nucleotide-binding protein G(k) subunit alpha |
PLCB1 |
PLCB1, KIAA0581: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta- |
2.83 |
Evidence |
|
| SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
HPCA |
HPCA, BDR2: Neuron-specific calcium-binding protein hippocalcin |
2.822 |
Evidence |
|
| MYL9 |
MYL9, MLC2, MRLC1, MYRL2: Myosin regulatory light chain 2, smooth muscle isoform |
BLNK |
BLNK, BASH, SLP65: B-cell linker protein |
2.822 |
Evidence |
|
| MYL9 |
MYL9, MLC2, MRLC1, MYRL2: Myosin regulatory light chain 2, smooth muscle isoform |
SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
2.822 |
Evidence |
|
| CDC7 |
CDC7, CDC7L1: Cell division cycle 7-related protein kinase |
CEBPA |
CEBPA: CCAAT/enhancer-binding protein alpha |
2.822 |
Evidence |
|
| RPS11 |
RPS11: 40S ribosomal protein S11 |
HRB2 |
KRR1, HRB2: KRR1 small subunit processome component homolog |
2.817 |
Evidence |
|
| TXN |
TXN, TRDX, TRX, TRX1: Thioredoxin |
PRDX5 |
PRDX5, ACR1, SBBI10: Peroxiredoxin-5, mitochondrial precursor |
2.817 |
Evidence |
|
| TMSB4X |
TMSB4X, TB4X, THYB4, TMSB4: Thymosin beta-4 |
CFL1 |
CFL1, CFL: Cofilin-1 |
2.815 |
Evidence |
|
| PTGIR |
PTGIR, PRIPR: Prostacyclin receptor |
GSK3A |
GSK3A: Glycogen synthase kinase-3 alpha |
2.815 |
Evidence |
|
| YWHAB |
YWHAB: 14-3-3 protein beta/alpha |
HDAC6 |
HDAC6, JM21: Histone deacetylase 6 |
2.815 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
SLC4A7 |
SLC4A7: Uncharacterized protein SLC4A7 |
2.815 |
Evidence |
|
| GCN5L2 |
GCN5L2, GCN5, HGCN5: General control of amino acid synthesis protein 5-like 2 |
ING2 |
ING2, ING1L: Inhibitor of growth protein 2 |
2.812 |
Evidence |
|
| NCOA2 |
NCOA2, TIF2: Nuclear receptor coactivator 2 |
GCN5L2 |
GCN5L2, GCN5, HGCN5: General control of amino acid synthesis protein 5-like 2 |
2.812 |
Evidence |
|
| RELB |
RELB: Transcription factor RelB |
PIAS4 |
PIAS4, PIASG: E3 SUMO-protein ligase PIAS4 |
2.812 |
Evidence |
|
| HIST1H3A |
HIST1H3A, H3FA, HIST1H3B, H3FL, HIST1H3C, H3FC, HIST1H3D, H3FB, HIST1H3E, H3FD, |
CBX1 |
CBX1, CBX: Chromobox protein homolog 1 |
2.812 |
Evidence |
|
| CSTF2 |
CSTF2: Cleavage stimulation factor 64 kDa subunit |
UBQLN3 |
UBQLN3: Ubiquilin-3 |
2.812 |
Evidence |
|
| PRKCH |
PRKCH, PKCL, PRKCL: Protein kinase C eta type |
TAGLN2 |
TAGLN2, RP11-48O20.1-003, hCG_39730: TAGLN2 protein |
2.812 |
Evidence |
|
| CCND1 |
CCND1, BCL1, PRAD1: G1/S-specific cyclin-D1 |
NR1H2 |
NR1H2, LXRB, NER, UNR: Oxysterols receptor LXR-beta |
2.812 |
Evidence |
|
- 
-